Journal
BMJ OPEN DIABETES RESEARCH & CARE
Volume 8, Issue 1, Pages -Publisher
BMJ PUBLISHING GROUP
DOI: 10.1136/bmjdrc-2020-001181
Keywords
metabolic syndrome; traditional Chinese medicine; high-quality study; blood glucose; randomized controlled trials
Categories
Funding
- Young Elite Scientists Sponsorship Program by CAST [YESS20170034, 2018QNRC2--C10]
- National Natural Science Foundation of China [81904187, 81274000, 81803923]
- Special Scientific Research for Traditional Chinese Medicine of China [201507001-11]
- Outstanding Young Scientific and Technological Talents Program [ZZ13--YQ-026]
Ask authors/readers for more resources
Metabolic syndrome (MetS) is a multifarious metabolic disorder that could severely damage multiple organs. The emergence of MetS has markedly increased medical burden for patients. The treatment of MetS involves multitarget regulation, which is the advantage of traditional Chinese medicine (TCM). Many high-quality studies related to TCM for MetS have been conducted in recent years; however, no overall efficacy analysis has been reported. To evaluate the efficacy and safety of TCM against MetS, we reviewed randomized controlled trials of MetS published in the past decade and then selected and analyzed 16 high-quality articles from over 800 papers. The results showed that TCM might be beneficial in improving body weight as well as in regulating glucose and lipid metabolisms; thus, TCM might be an ideal alternative therapy for MetS management. Treatment safety was also estimated in our analysis. A more elaborately designed and long-term observation of TCM for MetS should be performed in the future.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available